Number 1 brand in combating pain launches formula that promises to revolutionize the analgesic market

Dorflex, Sanofi's Consumer Healthcare brand, once again delivers a science-based solution so that Brazilians can move forward without worrying about pain. This is the new Dorflex MAX , with an exclusive formula with twice as much muscle relaxant and analgesic in a single tablet*, indicated to combat intense body pain, which can impact people on a daily basis.

To add innovation to the solution, it took more than 5 years of research by the Scientific Affairs unit, which reinforces the commitment to health and consumer needs, present at the center of decisions. The motto "Go ahead and leave the pain with us" continues with the mission of encouraging Brazilians, who struggle daily, about the importance of balance between pursuing goals and self-care.

Marília Zanoli

Consumer Healthcare Marketing Director at Sanofi

"Dorflex MAX highlights the commitment of our consumer unit to innovate and bring self-care - which is our great cause of agreement. And this only reinforces the power of the brand, 100% Brazilian and present in Brazilian homes for over 50 years. Dorflex is in the BrandZ ranking of the 50 most valuable Brazilian brands".

Stories inspired by real Brazilians

The launch continues the "Real Stories" campaign, which is currently on air, illustrated by Brazilians who, through creativity and determination, spare no effort to carry out their day-to-day activities. With this, the brand reinforces its positioning (Go ahead and leave the pain to us), being the care option in cases of pain. The campaign films are directed by Leandro HBL, from Bando Studio, and the audio production is by Fuzzr.

Silvio Silva

Commercial Director of Consumer Healthcare at Sanofi

" It is an enormous pride and satisfaction for the entire Dorflex team to bring yet another new product that delivers innovation and science to consumers. This result comes from an effort from many areas involved with the purpose of ensuring a pain-free and convenient routine for our audience, more a delivery for our consumers who are at the center of decision-making, in addition to the partnership we have with our customers to achieve this". 

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!